Summary
Deteriorated migration, axonal pathfinding and wiring of the brain is a main neuropathological feature of Down Syndrome (DS). Information on the underlying mechanisms is still limited, although basic functions of a series of growth factors, cell adhesion molecules, guidance factors and chemoattractants for brain histogenesis have been reported.
We used proteomics to detect differences in protein expression between control, DS and Alzheimer’s disease brains: In five individual brain regions of 9 individuals of each group we performed two dimensional electrophoresis with MALDI — identification of proteins and determined mRNA levels of DRP-2.
Significantly decreased mRNA levels of DRP-2 in four brain regions of patients with DS but not with AD as compared to controls were detected. 2D electrophoresis revealed variable expression of DRP-2 proteins, which showed a high heterogeneity per se. Dysregulation of DRP-2 was found in brains of patients with DS and AD presenting with an inconsistent pattern, which in turn may reflect the inconsistent neuropathological findings in patients with DS and AD.
The decrease of mRNA DRP-2 steady state levels in DS along with deteriorated protein expression of this repulsive guidance molecule of the semaphorin/collapsin family, may help to explain deranged migration and histogenesis of DS brain and wiring of AD brain.
Keywords
- Down Syndrome
- Collapsin Response Mediator Protein
- Growth Cone Collapse
- Axonal Pathfinding
- Down Syndrome Brain
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Becker LE, Armstrong DL, Chan F (1986) Dendritic atrophy in children with Down’s syndrome. Ann Neurol 20: 520–532
Becker L, Mito T, Takashima S, Onodera K (1991) Growth and development of the brain in Down Syndrome. In: Epstein CJ (ed) The morphogenesis of Down Syndrome. Wiley-Liss, New York, p 133
Bernert G, Nemethova M, Cairns N, Lubec G (1996) Decreased cyclin dependent kinase in brain of patients with Down Syndrome. Neurosci Lett 216: 68–70
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Byk T, Ozon S, Sobel A (1998) The ulip family phosphoproteins — common and specific properties. Eur J Biochem 254: 14–24
Crome L, Cowie V, Slater E (1966) A statistical note of cerebellar and brain stem weight in mongolism. J Ment Defic Res 10: 69–77
Drescher U, Kremoser C, Handwerker C, Loeschinger J, Noda M, Bonhoeffer F (1995) In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph — receptor tyrosine kinases. Cell 82: 359–370
Epstein CJ (1995) Down Syndrome (Trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp 749–794
Fountoulakis M, Langen H (1997) Identification of proteins by matrix-assisted laser desorption ionization-mass spectroscopy following in-gel digestion in low — salt, nonvolatile buffer and simplified peptide recovery. Anal Biochem 250: 153–156
Gaetano C, Matsuo T, Thiele CJ (1997) Identification and characterisation of a retinoic acid regulated human homologue of the unc-33-like phosphoprotein gene (hUlip) from neuroblastoma cells. J Biol Chem 272: 12195–12201
Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM (1995) Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376: 509–514
Goshima Y, Kawakami T, Hori H, Sugiyama Y, Takasawa S, Hashimoto Y, Kagoshima-Maezono M, Takenaka T, Misu Y, Strittmatter SM (1997) A novel action of collapsin: collapsin-1 increases antero-and retrograde axoplasmic transport independently of growth cone collapse. J Neurobiol 33: 316–328
Grenningloh G, Rehm EJ, Goodman CS (1991) Genetic analysis of growth cone guidance in Drosophila: fasciclin II functions as a neuronal recognition molecule. Cell 67: 45–57
Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki M, Nonaka M (1996) A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 180: 157–163
Jokusch H, Nave K-A, Grenningloh G, Schmitt-John T (1997) Molecular genetics of nervous and neruromuscular systems. In: Davies RW, Morris BJ (eds) Molecular biology of the neuron. BIOS Scientifique Publishers, Oxford, pp 21–66
Kolodkin AL, Matthes DJ, Goodman CS (1993) The semaphorin genes encode a family of transmembranre and secreted growth cone guidance molecules. Cell 75:1389–1399
Kuwada J (1995) Development of the zebrafish nervous system: genetic analysis and manipulation. Curr Opin Neurobiol 5: 50–54
Langen H, Roeder D, Juranville J-F, Fountoulakis M (1997) Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18: 2085–2090
Li W, Herman RK, Shaw JE (1992) Analysis of the Caenorhabditis elegans axonal guidance and outgrowth gene unc-33. Genetics 132: 675–689
Luo Y, Raible D, Raper JA (1993) Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75: 217–227
McMaster GK, Carmichael GG (1977) Analysis by single and double stranded nucleic acids on polytacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci (USA) 74: 4835–4841
Marin-Padilla M (1976) Pyramidal cell abnormalities in the motor cortex of a child with Down’s Syndrome. J Comp Neurol 167: 63–75
Minturn JE, Fryer HJ, Geschwind DH, Hockfield S (1995) TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C.elegans gene involved in axon outgrowth. J Neurosci 15: 6757–6766
Mirra SS, Heyman A, McKeel D, Sumi S, Crain B J (1991) The consortium to establish a registry for Alzheimer disease (CERAD). II. Standardisation of the neuro-pathological assessment of Alzheimer’s disease. Neurology 41: 479–486
Rehder H (1981) Pathology of trisomy 21. In: Burgio GR, Fraccaro M, Tiepolo L, Wolf U (eds) Trisomy 21. An International Symposium. Springer, Berlin Heidelberg New York Tokyo, p 57
Schmidt-Sidor B, Wisniewski KE, Shepard TH, Sersen A (1990) Brain growth in Down Syndrome subjects 15–22 weeks of gestational age and birth to 60 months. Clin Neuropathol 9: 181–195
Seeger M, Tear G, Ferres-Marco D, Goodman CS (1993) Mutations affecting growth cone guidance in Drosophila: genes necessary for guidance towards or away from the midline. Neuron 10: 409–426
Seidl R, Greber S, Schuller E, Bernert G, Cairns N, Lubec G (1997) Evidence against increased oxidative DNA-damage in Down Syndrome. Neurosci Lett 235: 137–140
Stahl B, Mueller B, von Boxberg Y, Cox EC, Bonhoeffer F (1990) Biochemical characterization of a putative axonal guidance molecule of the chick visual system. Neuron 5: 733–743
Sylvester PE (1986) The anterior commissure in Down’s syndrome. J Ment Defic Res 30: 19–25
Takashima S, Ieshima A, Nakamura H, Becker LE (1989) Dendrites, dementia and the Down Syndrome. Brain Dev 2: 131–143
Tierney MC, Fisher RH, Lewis AJ, Torzitto ML, Snow WG, Reid DW, Nieuwstraaten P, Van Rooijen LAA, Derks HJGM, Van Wijk R, Bischop A (1988) The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease. Neurology 38: 359–364
Van Vactor D, Sink H, Fambrough D, Tsoo R, Goodman CS (1993) Genes that control neuromuscular specificity in Drosophila. Cell 73: 1137–1153
Wang LH, Strittmatter SM (1996) A family of rat CRMP genes is differently expressed in the nervous system. J Neurosci 16: 6197–6207
White BA, Bancroft FC (1982) Cytoplasmic dot hybridization. Simple analysis of mRNA levels in multiple small cell or tissue samples. J Biol Chem 257: 8569–8575
Wisniewski KE, Bobinski M (1991) Hypothalamic abnormalities in Down syndrome. In: Epstein CJ (ed) The morphogenesis of Down Syndrome. Wiley — Liss, New York, p 153
Wisniewski KE, Laure-Kamionowska M, Connell F, Wen GY (1986) Neuronal density and synaptogenesis in the postnatal stage of brain maturation in Down syndrome. In: Epstein CJ (ed) The neurobiology of Down Syndrome. Raven, New York, p 29
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Wien
About this paper
Cite this paper
Lubec, G., Nonaka, M., Krapfenbauer, K., Gratzer, M., Cairns, N., Fountoulakis, M. (1999). Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down Syndrome and Alzheimer’s disease brain is downregulated at the mRNA and dysregulated at the protein level. In: Lubec, G. (eds) The Molecular Biology of Down Syndrome. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6380-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6380-1_10
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83377-3
Online ISBN: 978-3-7091-6380-1
eBook Packages: Springer Book Archive